Eli Lilly and Company and Innovent Biologics, Inc., announced one of the largest biotech drug development collaborations in China thus far today in Beijing. Under the agreement, Lilly and Innovent will collaborate to develop and potentially commercialize at least three cancer treatments over the next decade. The agreement creates … Read More